Importantly, our data indicate that a treatment schedule in which a short Plk1 inhibition using BI2536 is performed before IR reduces the formation of BRCA1 and Rad51 foci, leading to impaired HR repair and to radiosensitization of cancer cells. Here, PLK1 is linked to cancer.